Turtlemint Fintech, Yashoda Hospitals Among 7 IPOs to Get SEBI Approval

India’s primary market is gearing up for a fresh wave of public offerings as the Securities and Exchange Board of India (SEBI) has granted its regulatory approval to seven companies, including a leading fintech and a major healthcare chain. Among the firms clearing the initial compliance milestone are Turtlemint Fintech Solutions and Yashoda Healthcare Services, bringing diverse sectors such as digital financial services, healthcare, retail, manufacturing, and environmental engineering into the spotlight.

Receiving SEBI “observations” on draft red herring prospectuses (DRHPs) signals that these companies can now proceed with their Initial Public Offerings (IPOs) within the stipulated regulatory timelines. This development reflects a broader resurgence in India’s IPO market, driven by strong investor interest and robust demand for quality primary market investment opportunities.

SEBI APPROVES SEVEN IPOs ACROSS SECTORS

In a move that underscores the breadth of India’s economic growth story, seven companies spanning fintech, healthcare, retail, manufacturing, and environmental solutions have secured SEBI’s nod to file IPO prospectuses and move toward public offerings.

Notable IPO Approvals

• Turtlemint Fintech Solutions – A technology-driven insurance distribution and fintech platform that connects customers, advisers, and insurers. The company filed its DRHP via the confidential route.
• Yashoda Healthcare Services – The operator of the Yashoda Hospitals chain based in Hyderabad, looking to raise an estimated ₹3,000–4,000 crore via its IPO.
• Fusion CX – A customer experience services provider planning a roughly ₹1,000 crore IPO, with a mix of fresh issue and offer for sale.
• Orient Cables (India) – Manufacturer of passive networking and telecom cables, aiming for a ₹700 crore issue.
• RSB Retail India – Parent company of the R.S. Brothers apparel retail chain.
• SFC Environmental Technologies – Provider of environmental engineering and wastewater treatment solutions.
• Lohia Corp – Technical textile machinery manufacturer, pursuing an offer-for-sale IPO.

These approvals were issued based on draft filings submitted between May and September 2025, with SEBI’s observations arriving between December 8 and December 12. The total expected fundraising from these seven companies is estimated to be over ₹6,000 crore once their IPOs hit the market.

WHAT SEBI APPROVAL MEANS — AND WHY IT MATTERS

In SEBI’s regulatory framework, issuing “observations” on a company’s DRHP means the regulator has completed its initial review and found the filing compliant with public issuance norms. The next steps typically involve:

• Filing an Updated Draft Red Herring Prospectus (UDRHP)
• Public marketing and roadshows
• Fixing a price band before the IPO opens for subscription

For companies that filed via the confidential route, such as Turtlemint and Yashoda Hospitals, this also means they now have up to 18 months to complete the IPO, giving them flexibility in timing and market positioning.

The approval is significant for both issuers and investors. For issuers, it means access to broader capital pools, potential brand recognition, and enhanced credibility. For investors, a rich pipeline of offerings provides diversified opportunities in sectors poised for growth — especially in fintech and healthcare, which remain resilient amid market cycles.

SECTORAL INSIGHTS: FINTECH & HEALTHCARE TAKE CENTER STAGE

Fintech Industry Momentum

Turtlemint Fintech Solutions operates at the crossroads of insurance, technology, and financial services. Founded in 2015 and backed by marquee investors including Amansa Capital, Jungle Ventures, and Nexus Venture Partners, the company has facilitated the sale of over 1.6 crore insurance policies through a network of more than 5 lakh advisers.

Today’s approval adds to a string of fintech firms preparing to tap public markets, reflecting increasing investor appetite for technology-enabled financial distribution platforms that combine scale, data insights, and recurring revenue potential.

Healthcare Sector Strength

Healthcare remains a reliable growth theme in India. Yashoda Healthcare Services operates multiple multi-speciality hospitals with dedicated heart and cancer institutes, boasting a combined capacity of around 4,000 beds. Its expected IPO size — reported to be between ₹3,000 and ₹4,000 crore — underscores investor confidence in healthcare providers with strong regional footprints and specialised services.

The strong presence of healthcare, fintech, and diversified industrial names in this IPO cohort reflects both demand diversity and market maturity, as India’s capital markets expand beyond traditional incumbents into emerging sectors.

WHAT THIS MEANS FOR THE PRIMARY MARKET IN 2026

The cluster of approvals aligns with a broader trend in India’s primary markets, which have shown renewed momentum throughout 2025. High-profile offerings — such as the oversubscribed ICICI Prudential AMC IPO earlier in December — have helped restore investor enthusiasm and confidence.

A fresh pipeline that now includes fintech, healthcare, retail, manufacturing, and environmental engineering companies is likely to support continued IPO activity into 2026. This suggests that India’s capital markets are not only recovering but also diversifying in scope, attracting participation from both institutional and retail investors.

If properly timed and marketed, these offerings could set the stage for a robust primary market season, built on both domestic savings and participation from global funds looking for exposure to structural growth themes.

CONCLUSION

SEBI’s approval of IPO plans for seven companies, including Turtlemint Fintech Solutions and Yashoda Healthcare Services, marks a significant milestone in India’s capital markets. With diverse sectors represented and substantial fundraising anticipated, this development reflects a maturing primary market that balances innovation, growth potential, and investor interest.

For issuers, the regulatory green light is the first step in unlocking broader public capital — a journey that will unfold over the coming months. For investors, the expanding IPO pipeline offers an array of new investment opportunities across technology, healthcare, retail, engineering, and environmental services.

The coming IPO season promises to be one of the most dynamic in recent memory, with strategic offerings that could reshape market narratives and investor portfolios alike.

#FintechIPO#HealthcareIPO#IndianMarkets#PrimaryMarket#Turtlemint#YashodaHealthcareIPOSEBITheFinRate